Non-small Cell Lung Cancer Therapeutics Market Size, Share & Trends Analysis Report By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza), By Region, & Segment Forecasts, 2018 - 2025
- Report ID: GVR-1-68038-703-2
- Number of Pages: 100
- Format: Electronic (PDF)
- Historical Range: 2014 - 2016
- 工业:Healthcare
Market Segmentation
- Non-small Cell Lung Cancer Therapeutics Drug Outlook (Revenue, USD Million,2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Non-small Cell Lung Cancer Therapeutics Regional Outlook (Revenue, USD Million,2014 - 2025)
- North America
- The U.S.
- U.S. Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- U.S. Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Canada
- Canada Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Canada Drug Outlook (Revenue, USD Million, 2014 - 2025)
- The U.S.
- Europe
- UK
- UK Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- UK Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Germany
- Germany Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Germany Drug Outlook (Revenue, USD Million, 2014 - 2025)
- UK
- Asia Pacific
- Japan
- Japan Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Japan Drug Outlook (Revenue, USD Million, 2014 - 2025)
- China
- China Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- China Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Japan
- Latin America
- Brazil
- Brazil Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Brazil Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Mexico
- Mexico Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- Mexico Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Brazil
- MEA
- South Africa
- South Africa Drug Outlook (Revenue, USD Million, 2014 - 2025)
- Alimta
- Iressa
- Avastin
- Tarceva
- Zykadia
- Tagrisso
- Xalkori
- Cyramza
- Opdivo
- Alecensa
- South Africa Drug Outlook (Revenue, USD Million, 2014 - 2025)
- South Africa
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- 乐鱼体育手机网站入口
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2014 to 2025
- Market estimates and forecast for product segments up to 2025
- Regional market size and forecast for product segments up to 2025
- Market estimates and forecast for application segments up to 2025
- Regional market size and forecast for application segments up to 2025
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us nowto get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.
